AGBA Acquisition (AGBAW) has had the highest return since January 1, 2024 by a US stock, returning 2,726.2%.
ASSET | % RETURN |
---|---|
AGBA Acquisition (AGBAW) | 2,726.23% |
Codere Online Luxembourg SA Warrants (CDROW) | 1,385.15% |
Palladyne AI (PDYNW) | 999% |
Nexalin Technology (NXLIW) | 909.86% |
Bone Biologics Corp Warrants (BBLGW) | 798.18% |
LENZ Therapeutics (LENZ) | 796.58% |
Solowin Holdings Ordinary Share (SWIN) | 781.91% |
AdTheorent (ADTHW) | 748.48% |
Cheetah Net Supply Chain Service Inc Class A Common Stock (CTNT) | 730.77% |
GeneDx (WGS) | 729.26% |
Binah Capital Group, Inc Warrants (BCGWW) | 683.48% |
Candel Therapeutics (CADL) | 671.81% |
Fitell Corporation Ordinary Shares (FTEL) | 656.58% |
Corbus Pharmaceuticals (CRBP) | 648.75% |
Breeze Holdings Acquisition (BREZW) | 623.08% |
MMTEC (MTC) | 614.14% |
SRAX (SRAX) | 599.3% |
Elevation Oncology (ELEV) | 568.52% |
Biofrontera Inc Warrants (BFRIW) | 550% |
Armada Acquisition Corp I Warrant (AACIW) | 550% |
iPower (IPW) | 542.22% |
Liberty Resources Acquisition Corp Warrant (LIBYW) | 542% |
Digital Health Acquisition Corp Warrant (DHACW) | 533.7% |
Root (ROOT) | 529.37% |
Dave (DAVE) | 511.41% |